Raymond James & Associates’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-112
| Closed | -$1.19K | – | 3964 |
|
|
2023
Q4 | $1.19K | Sell |
112
-70
| -38% | -$741 | ﹤0.01% | 3763 |
|
|
2023
Q3 | $3.59K | Sell |
182
-226
| -55% | -$4.46K | ﹤0.01% | 3739 |
|
|
2023
Q2 | $31.2K | Hold |
408
| – | – | ﹤0.01% | 3689 |
|
|
2023
Q1 | $38.6K | Sell |
408
-36
| -8% | -$3.4K | ﹤0.01% | 3704 |
|
|
2022
Q4 | $43.3K | Buy |
444
+3
| +0.7% | +$292 | ﹤0.01% | 3669 |
|
|
2022
Q3 | $114K | Sell |
441
-50
| -10% | -$12.9K | ﹤0.01% | 3556 |
|
|
2022
Q2 | $91K | Sell |
491
-3
| -0.6% | -$556 | ﹤0.01% | 3655 |
|
|
2022
Q1 | $48K | Sell |
494
-66
| -12% | -$6.41K | ﹤0.01% | 3839 |
|
|
2021
Q4 | $92K | Buy |
560
+10
| +2% | +$1.64K | ﹤0.01% | 3827 |
|
|
2021
Q3 | $150K | Sell |
550
-47
| -8% | -$12.8K | ﹤0.01% | 3711 |
|
|
2021
Q2 | $237K | Sell |
597
-44
| -7% | -$17.5K | ﹤0.01% | 3558 |
|
|
2021
Q1 | $346K | Sell |
641
-21
| -3% | -$11.3K | ﹤0.01% | 3238 |
|
|
2020
Q4 | $250K | Sell |
662
-49
| -7% | -$18.5K | ﹤0.01% | 3214 |
|
|
2020
Q3 | $269K | Sell |
711
-14
| -2% | -$5.3K | ﹤0.01% | 3001 |
|
|
2020
Q2 | $357K | Buy |
725
+34
| +5% | +$16.7K | ﹤0.01% | 2805 |
|
|
2020
Q1 | $254K | Buy |
691
+218
| +46% | +$80.1K | ﹤0.01% | 2865 |
|
|
2019
Q4 | $335K | Buy |
473
+146
| +45% | +$103K | ﹤0.01% | 3004 |
|
|
2019
Q3 | $210K | Buy |
327
+6
| +2% | +$3.85K | ﹤0.01% | 3207 |
|
|
2019
Q2 | $281K | Sell |
321
-81
| -20% | -$70.9K | ﹤0.01% | 3032 |
|
|
2019
Q1 | $232K | Buy |
402
+27
| +7% | +$15.6K | ﹤0.01% | 3125 |
|
|
2018
Q4 | $105K | Sell |
375
-12
| -3% | -$3.36K | ﹤0.01% | 3276 |
|
|
2018
Q3 | $186K | Sell |
387
-2
| -0.5% | -$961 | ﹤0.01% | 3294 |
|
|
2018
Q2 | $176K | Buy |
389
+244
| +168% | +$110K | ﹤0.01% | 3276 |
|
|
2018
Q1 | $85K | Hold |
145
| – | – | ﹤0.01% | 3254 |
|
|
2017
Q4 | $90K | Sell |
145
-90
| -38% | -$55.9K | ﹤0.01% | 3182 |
|
|
2017
Q3 | $216K | Hold |
235
| – | – | ﹤0.01% | 2978 |
|
|
2017
Q2 | $219K | Sell |
235
-7
| -3% | -$6.52K | ﹤0.01% | 2901 |
|
|
2017
Q1 | $230K | Buy |
242
+26
| +12% | +$24.7K | ﹤0.01% | 2826 |
|
|
2016
Q4 | $173K | Sell |
216
-23
| -10% | -$18.4K | ﹤0.01% | 2890 |
|
|
2016
Q3 | $202K | Sell |
239
-84
| -26% | -$71K | ﹤0.01% | 2824 |
|
|
2016
Q2 | $266K | Sell |
323
-8
| -2% | -$6.59K | ﹤0.01% | 2474 |
|
|
2016
Q1 | $369K | Sell |
331
-12
| -3% | -$13.4K | ﹤0.01% | 2212 |
|
|
2015
Q4 | $427K | Buy |
343
+189
| +123% | +$235K | ﹤0.01% | 2065 |
|
|
2015
Q3 | $208K | Buy |
154
+18
| +13% | +$24.3K | ﹤0.01% | 2240 |
|
|
2015
Q2 | $244K | Sell |
136
-190
| -58% | -$341K | ﹤0.01% | 2322 |
|
|
2015
Q1 | $527K | Buy |
+326
| New | +$527K | ﹤0.01% | 2011 |
|